A detailed history of New York State Common Retirement Fund transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 69,292 shares of PCRX stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,292
Previous 50,696 36.68%
Holding current value
$1.13 Million
Previous $1.45 Million 28.07%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$11.7 - $28.46 $217,573 - $529,242
18,596 Added 36.68%
69,292 $1.04 Million
Q2 2024

Jul 31, 2024

BUY
$25.5 - $31.51 $173,502 - $214,394
6,804 Added 15.5%
50,696 $1.45 Million
Q1 2024

May 07, 2024

BUY
$27.7 - $35.48 $495,276 - $634,382
17,880 Added 68.74%
43,892 $1.28 Million
Q4 2023

Feb 01, 2024

SELL
$26.32 - $34.31 $197,584 - $257,565
-7,507 Reduced 22.4%
26,012 $878,000
Q3 2023

Nov 07, 2023

SELL
$30.68 - $40.09 $328,889 - $429,764
-10,720 Reduced 24.23%
33,519 $1.03 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $47.5 $68,302 - $89,822
1,891 Added 4.47%
44,239 $1.77 Million
Q1 2023

May 02, 2023

SELL
$35.53 - $43.38 $333,129 - $406,730
-9,376 Reduced 18.13%
42,348 $1.73 Million
Q4 2022

Jan 30, 2023

BUY
$38.19 - $57.45 $3,093 - $4,653
81 Added 0.16%
51,724 $2 Million
Q3 2022

Nov 08, 2022

SELL
$51.24 - $58.89 $1.91 Million - $2.19 Million
-37,241 Reduced 41.9%
51,643 $2.75 Million
Q2 2022

Aug 04, 2022

SELL
$51.49 - $81.64 $3.83 Million - $6.07 Million
-74,358 Reduced 45.55%
88,884 $5.18 Million
Q1 2022

May 05, 2022

BUY
$60.03 - $76.49 $7.58 Million - $9.65 Million
126,192 Added 340.6%
163,242 $12.5 Million
Q4 2021

Feb 02, 2022

SELL
$47.97 - $62.21 $724,203 - $939,184
-15,097 Reduced 28.95%
37,050 $2.23 Million
Q3 2021

Nov 02, 2021

SELL
$54.64 - $61.3 $139,495 - $156,498
-2,553 Reduced 4.67%
52,147 $2.92 Million
Q2 2021

Aug 02, 2021

SELL
$59.18 - $69.99 $346,794 - $410,141
-5,860 Reduced 9.68%
54,700 $3.32 Million
Q1 2021

May 11, 2021

BUY
$59.31 - $78.82 $670,914 - $891,611
11,312 Added 22.97%
60,560 $4.25 Million
Q4 2020

Feb 08, 2021

SELL
$50.47 - $66.26 $778,802 - $1.02 Million
-15,431 Reduced 23.86%
49,248 $2.95 Million
Q3 2020

Nov 05, 2020

BUY
$51.97 - $63.0 $32,948 - $39,942
634 Added 0.99%
64,679 $3.89 Million
Q2 2020

Aug 07, 2020

SELL
$30.8 - $52.47 $13,428 - $22,876
-436 Reduced 0.68%
64,045 $3.36 Million
Q1 2020

May 06, 2020

BUY
$28.4 - $50.7 $2,840 - $5,070
100 Added 0.16%
64,481 $2.16 Million
Q4 2019

Feb 05, 2020

SELL
$36.31 - $46.83 $107,114 - $138,148
-2,950 Reduced 4.38%
64,381 $2.92 Million
Q3 2019

Nov 07, 2019

SELL
$35.66 - $44.99 $4.92 Million - $6.21 Million
-137,930 Reduced 67.2%
67,331 $2.56 Million
Q2 2019

Aug 09, 2019

BUY
$36.57 - $47.97 $269,740 - $353,826
7,376 Added 3.73%
205,261 $8.93 Million
Q1 2019

May 08, 2019

BUY
$36.47 - $42.17 $682,827 - $789,548
18,723 Added 10.45%
197,885 $7.53 Million
Q4 2018

Feb 08, 2019

SELL
$41.31 - $52.16 $650,136 - $820,894
-15,738 Reduced 8.07%
179,162 $7.71 Million
Q3 2018

Nov 07, 2018

BUY
$32.85 - $52.0 $354,287 - $560,820
10,785 Added 5.86%
194,900 $9.58 Million
Q2 2018

Aug 10, 2018

SELL
$27.5 - $39.8 $822,140 - $1.19 Million
-29,896 Reduced 13.97%
184,115 $5.9 Million
Q1 2018

May 10, 2018

BUY
$29.98 - $46.35 $925,812 - $1.43 Million
30,881 Added 16.86%
214,011 $6.67 Million
Q4 2017

Feb 13, 2018

BUY
$31.85 - $46.95 $515,842 - $760,402
16,196 Added 9.7%
183,130 $8.36 Million
Q3 2017

Nov 06, 2017

SELL
$35.7 - $39.5 $110,848 - $122,647
-3,105 Reduced 1.83%
166,934 $6.27 Million
Q2 2017

Aug 11, 2017

BUY
N/A
170,039
170,039 $8.11 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $750M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.